MedPath

Navinta LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

16

FDA:10
SFDA:5
NMPA:1

Drug Approvals

Trientine Hydrochloride Capsules

Product Name
盐酸曲恩汀胶囊
Approval Number
国药准字HJ20240087
Approval Date
Aug 27, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.